| scholarly article | Q13442814 |
| P50 | author | Carey Farquhar | Q96781744 |
| Rose Bosire | Q124624698 | ||
| Grace John-Stewart | Q47146705 | ||
| Barbra A Richardson | Q60608309 | ||
| P2093 | author name string | Dorothy A Mbori-Ngacha | |
| Joan K Kreiss | |||
| Thomas C VanCott | |||
| Lena Horani | |||
| P2860 | cites work | Orogenital sex and the transmission of HIV among homosexual men | Q68089687 |
| Clinical and epidemiologic features of primary HIV infection | Q71182378 | ||
| Secretory leukocyte protease inhibitor in colostrum and breast milk is not a major determinant of the protection of early postnatal transmission of HIV | Q73343749 | ||
| Identification of a novel secretory leukocyte protease inhibitor-binding protein involved in membrane phospholipid movement | Q28139286 | ||
| Secretory leukocyte protease inhibitor: a human saliva protein exhibiting anti-human immunodeficiency virus 1 activity in vitro | Q28293679 | ||
| Endogenous mucosal antiviral factors of the oral cavity | Q33547138 | ||
| Rapid method for screening dried blood samples on filter paper for human immunodeficiency virus type 1 DNA | Q33958648 | ||
| Human immunodeficiency virus (HIV)-specific cellular immune responses in newborns exposed to HIV in utero | Q34461381 | ||
| Mother-to-child transmission of human immunodeficiency virus type 1. | Q36023805 | ||
| Cervical human immunodeficiency virus type 1 shedding is associated with genital beta-chemokine secretion. | Q41001667 | ||
| Secretory leukocyte protease inhibitor in vaginal fluids and perinatal human immunodeficiency virus type 1 transmission | Q45738773 | ||
| Secretory leukocyte protease inhibitor blocks infectivity of primary monocytes and mononuclear cells with both monocytotropic and lymphocytotropic strains of human immunodeficiency virus type I. | Q45758044 | ||
| Inhibition of human immunodeficiency virus type 1 infectivity by secretory leukocyte protease inhibitor occurs prior to viral reverse transcription | Q45761404 | ||
| Association between biological properties of human immunodeficiency virus variants and risk for AIDS and AIDS mortality | Q45844635 | ||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1173-1176 | |
| P577 | publication date | 2002-09-20 | |
| P1433 | published in | Journal of Infectious Diseases | Q4051141 |
| P1476 | title | Salivary secretory leukocyte protease inhibitor is associated with reduced transmission of human immunodeficiency virus type 1 through breast milk | |
| P478 | volume | 186 |
| Q35577249 | Alpha-defensins in the prevention of HIV transmission among breastfed infants. |
| Q35868058 | Anti-HIV-1 activity of elafin is more potent than its precursor's, trappin-2, in genital epithelial cells |
| Q33715960 | Anti-inflammatory and antimicrobial roles of secretory leukocyte protease inhibitor |
| Q38551779 | Antiviral activities of whey proteins |
| Q35598969 | Breast milk and HIV-1: vector of transmission or vehicle of protection? |
| Q35628427 | Breast-feeding and Transmission of HIV-1. |
| Q45987785 | Breastfeeding Behaviors and the Innate Immune System of Human Milk: Working Together to Protect Infants against Inflammation, HIV-1, and Other Infections. |
| Q46332296 | Breastfeeding in HIV-positive women: What can be recommended? |
| Q37693958 | Cervical intraepithelial neoplasia is associated with genital tract mucosal inflammation |
| Q36095139 | Cervicovaginal levels of lactoferrin, secretory leukocyte protease inhibitor, and RANTES and the effects of coexisting vaginoses in human immunodeficiency virus (HIV)-seronegative women with a high risk of heterosexual acquisition of HIV infection |
| Q35075174 | Comparison of human immunodeficiency virus type 1-specific inhibitory activities in saliva and other human mucosal fluids |
| Q93042019 | Determinants of Tenascin-C and HIV-1 envelope binding and neutralization |
| Q37596710 | Estimation and comparison of salivary secretory leukocyte protease inhibitor in human immunodeficiency virus patients and healthy individuals |
| Q36317084 | Exclusive breastfeeding reduces risk of mortality in infants up to 6 mo of age born to HIV-positive Tanzanian women |
| Q34680240 | Female genital tract secretions and semen impact the development of microbicides for the prevention of HIV and other sexually transmitted infections |
| Q35030053 | Genetic and Immunological Factors Involved in Natural Resistance to HIV-1 Infection |
| Q36898823 | Herpes simplex virus downregulates secretory leukocyte protease inhibitor: a novel immune evasion mechanism |
| Q36069338 | High uptake of postpartum hormonal contraception among HIV-1-seropositive women in Kenya |
| Q49056588 | Human buccal epithelium acquires microbial hyporesponsiveness at birth, a role for secretory leukocyte protease inhibitor. |
| Q33780434 | Human immunodeficiency virus type 1 stimulates the expression and production of secretory leukocyte protease inhibitor (SLPI) in oral epithelial cells: a role for SLPI in innate mucosal immunity |
| Q36049157 | Human leukocyte antigen (HLA) B*18 and protection against mother-to-child HIV type 1 transmission |
| Q36640429 | Impact of microbicides and sexually transmitted infections on mucosal immunity in the female genital tract |
| Q42214247 | In-utero infection with HIV-1 associated with suppressed lymphoproliferative responses at birth. |
| Q47812016 | Infants with late breast milk acquisition of HIV-1 generate interferon-gamma responses more rapidly than infants with early peripartum acquisition |
| Q24801159 | Innate immune defences in the human endometrium |
| Q33843438 | Longitudinal assessment of human immunodeficiency virus type 1 (HIV-1)-specific gamma interferon responses during the first year of life in HIV-1-infected infants |
| Q35458113 | Novel vaginal microflora colonization model providing new insight into microbicide mechanism of action |
| Q37742900 | Older rhesus macaque infants are more susceptible to oral infection with simian-human immunodeficiency virus 89.6P than neonates |
| Q34526020 | Oral transmission of HIV, reality or fiction? An update |
| Q33927135 | Phenotypic characterization of HIV-specific CD8+ T cells during early and chronic infant HIV-1 infection |
| Q36996000 | Plasma and mucosal HIV viral loads are associated with genital tract inflammation in HIV-infected women |
| Q37936541 | SLPI and elafin: multifunctional antiproteases of the WFDC family. |
| Q33399887 | Safety analysis of the diaphragm in combination with lubricant or acidifying microbicide gels: effects on markers of inflammation and innate immunity in cervicovaginal fluid |
| Q45394795 | Salivary human immunodeficiency virus (HIV)-1-specific immunoglobulin A in HIV-1-exposed infants in Kenya |
| Q36177527 | Short communication: Increased expression of secretory leukocyte protease inhibitor in oral mucosa of Colombian HIV type 1-exposed seronegative individuals |
| Q35190200 | Systemic and mucosal differences in HIV burden, immune, and therapeutic responses |
| Q36018536 | The Presence and Anti-HIV-1 Function of Tenascin C in Breast Milk and Genital Fluids |
| Q37336986 | The detection of cytomegalovirus DNA in maternal plasma is associated with mortality in HIV-1-infected women and their infants |
| Q33874252 | The mouth: a gateway or a trap for HIV? |
| Q37290154 | The oral mucosa immune environment and oral transmission of HIV/SIV. |
| Q21143809 | The phospholipid scramblases 1 and 4 are cellular receptors for the secretory leukocyte protease inhibitor and interact with CD4 at the plasma membrane |
| Q35000080 | The role of cell-associated virus in mother-to-child HIV transmission |
| Q35591075 | The role of infant immune responses and genetic factors in preventing HIV-1 acquisition and disease progression |
| Q34014618 | Toll-like receptor variants are associated with infant HIV-1 acquisition and peak plasma HIV-1 RNA level |
| Q24795604 | Viral and immunological factors associated with breast milk transmission of SIV in rhesus macaques |
| Q24657262 | WFDC1/ps20 is a novel innate immunomodulatory signature protein of human immunodeficiency virus (HIV)-permissive CD4+ CD45RO+ memory T cells that promotes infection by upregulating CD54 integrin expression and is elevated in HIV type 1 infection |
Search more.